- Sapien Biosciences
... Fresh tumor and adjacent non-tumor samples Hematological tumors Blood, Plasma, Serum Saliva, Urine, BAL, Pleural fluid, synovial fluid etc. Non-diseased specimens ...
... Fresh tumor and adjacent non-tumor samples Hematological tumors Blood, Plasma, Serum Saliva, Urine, BAL, Pleural fluid, synovial fluid etc. Non-diseased specimens ...
renal cell carcinoma fact sheet
... cancer has metastasized to other parts of the body, only about 12% of patients will live longer than five years following their diagnosis7. Therefore, it is important to identify and diagnose RCC at early stages5,7. If RCC is diagnosed in the early stages before it has spread to other parts of the b ...
... cancer has metastasized to other parts of the body, only about 12% of patients will live longer than five years following their diagnosis7. Therefore, it is important to identify and diagnose RCC at early stages5,7. If RCC is diagnosed in the early stages before it has spread to other parts of the b ...
Spotlight
... origin of several cancers affecting both human and dog. Analysis of our data has revealed that we are well on the way towards development of more sophisticated molecular sub-classification of canine, and possibly human, cancers. This approach should facilitate the emergence of improved and tailored ...
... origin of several cancers affecting both human and dog. Analysis of our data has revealed that we are well on the way towards development of more sophisticated molecular sub-classification of canine, and possibly human, cancers. This approach should facilitate the emergence of improved and tailored ...
Personal Genome Diagnostics Announces AACR Annual Meeting
... identify tumor neoantigens and support development of cancer immunotherapies. The service combines the high accuracy of PGDx’s CancerXomeTM analysis with its proprietary bioinformatics neoantigen prediction pipeline. The study data demonstrate that the company’s combined tissue processing, macrodiss ...
... identify tumor neoantigens and support development of cancer immunotherapies. The service combines the high accuracy of PGDx’s CancerXomeTM analysis with its proprietary bioinformatics neoantigen prediction pipeline. The study data demonstrate that the company’s combined tissue processing, macrodiss ...
GlOSSARY OF COMMON FORMS OF CANCER
... blood cells. There are two main groups, acute myeloid leukemia and chronic myelogenous leukemia; there are eight subtypes of acute myeloid leukemia. Nonmyeloid cancers: All cancers other than myeloid leukemias. These nonmyeloid cancers include all types of carcinoma, sarcoma, melanoma, lymphomas, ly ...
... blood cells. There are two main groups, acute myeloid leukemia and chronic myelogenous leukemia; there are eight subtypes of acute myeloid leukemia. Nonmyeloid cancers: All cancers other than myeloid leukemias. These nonmyeloid cancers include all types of carcinoma, sarcoma, melanoma, lymphomas, ly ...
Understanding progressive disease
... The study assesses the quality of routine national datasets for analysing progressive cancer, and determines how these data can be used to develop a methodology to identify cancer progression. The project is in the early stages, but initial analysis will be complete later this year. There are a numb ...
... The study assesses the quality of routine national datasets for analysing progressive cancer, and determines how these data can be used to develop a methodology to identify cancer progression. The project is in the early stages, but initial analysis will be complete later this year. There are a numb ...
The Role of Alternative Polyadenylation in Glioblastoma
... The University of Texas Medical Branch at Galveston Lay Summary: Glioblastoma (GBM) is the most prevalent and malignant primary brain tumor. The unfortunate combination of its infiltrative growth and aggressive phenotype prevents virtually any positive clinical outcome. The Cancer Genome Atlas proje ...
... The University of Texas Medical Branch at Galveston Lay Summary: Glioblastoma (GBM) is the most prevalent and malignant primary brain tumor. The unfortunate combination of its infiltrative growth and aggressive phenotype prevents virtually any positive clinical outcome. The Cancer Genome Atlas proje ...
Symposium Directory
... method for generating whole-transcriptome RNA sequencing libraries from moderate to poor quality FFPE samples starting with as low as 20ng total RNA. This approach provides increased transcriptome coverage and robust measurement of gene expression levels compared to established FFPE RNA sequencing m ...
... method for generating whole-transcriptome RNA sequencing libraries from moderate to poor quality FFPE samples starting with as low as 20ng total RNA. This approach provides increased transcriptome coverage and robust measurement of gene expression levels compared to established FFPE RNA sequencing m ...
Hydrogels for bladder cancer
... Bladder carcinoma is the second commonest urological carcinoma after prostate cancer. In US, there are 72,570 new cases of bladder cancer in 2013 and causing 15.210 deaths (http://www.cancer.gov/cancertopics/types/bladder). In China, there is an increasing trend in the incidence of bladder cancer fr ...
... Bladder carcinoma is the second commonest urological carcinoma after prostate cancer. In US, there are 72,570 new cases of bladder cancer in 2013 and causing 15.210 deaths (http://www.cancer.gov/cancertopics/types/bladder). In China, there is an increasing trend in the incidence of bladder cancer fr ...
UCL Cancer Institute JOB DESCRIPTION POST: Research
... of Academic Pathology at UCL/UCLH. She is also Cancer Lead North for the North Thames Genomic Medicine Centre. The remit of this post is to undertake research and provide computational and analytical support for the Flanagan group who are involved in sequencing projects with the aim of developing di ...
... of Academic Pathology at UCL/UCLH. She is also Cancer Lead North for the North Thames Genomic Medicine Centre. The remit of this post is to undertake research and provide computational and analytical support for the Flanagan group who are involved in sequencing projects with the aim of developing di ...
Merkel*s Cell Carcinoma
... small, red, pink, or blue-violet, non-ulcerated, painless, intradermal nodular mass often located in sun-exposed areas of the skin such as the head and neck ...
... small, red, pink, or blue-violet, non-ulcerated, painless, intradermal nodular mass often located in sun-exposed areas of the skin such as the head and neck ...
Identification of Lung Cancer Biomarkers in the Clinical Molecular
... for mutation analysis from a panel of 50 genes. The results of this test indicate that tumor cells comprising 25.0% of the tissue specimen analyzed were normal for BRAF, KRAS and hotspots in 46 other genes. A p.L858R activating mutation was detected in exon 21 of the EGFR gene suggesting that this p ...
... for mutation analysis from a panel of 50 genes. The results of this test indicate that tumor cells comprising 25.0% of the tissue specimen analyzed were normal for BRAF, KRAS and hotspots in 46 other genes. A p.L858R activating mutation was detected in exon 21 of the EGFR gene suggesting that this p ...
Sequencers - UT Austin Wikis - The University of Texas at Austin
... Farber both predict sequencing of all incoming cancer patients in the next 2-3 years Applications will be: ...
... Farber both predict sequencing of all incoming cancer patients in the next 2-3 years Applications will be: ...
PhD studentship - Development of preclinical models of High Grade
... This project is ideal for candidates seeking experience in transitional research, who will work in a multidisciplinary team of clinicians and scientists. For up to date information about the research group, including their most recent publications, please see their website at: http://www.cruk.cam.ac ...
... This project is ideal for candidates seeking experience in transitional research, who will work in a multidisciplinary team of clinicians and scientists. For up to date information about the research group, including their most recent publications, please see their website at: http://www.cruk.cam.ac ...
DNA sequence analysis software aids clinical practice
... “One of the first activities of the company was to develop our own variant caller, building on the expertise we developed implementing the original variant caller software and applying it in our earlier project. That was a direct result of the activity in the BBSRC project.” The company is also look ...
... “One of the first activities of the company was to develop our own variant caller, building on the expertise we developed implementing the original variant caller software and applying it in our earlier project. That was a direct result of the activity in the BBSRC project.” The company is also look ...
NCI CBIIT Re
... to incorporate clinical standards into research where ever and whenever appropriate • Our ability to semantically reason and make inference over diverse data types is critical to realizing the goals of Precision Oncology • NLP, ontologies, checklists, CDEs embedded in forms will let us move to next ...
... to incorporate clinical standards into research where ever and whenever appropriate • Our ability to semantically reason and make inference over diverse data types is critical to realizing the goals of Precision Oncology • NLP, ontologies, checklists, CDEs embedded in forms will let us move to next ...
EGFR - Research To Practice
... • Discovery of more than 1,000 somatic mutations after sequencing 623 genes with known or potential relationships to cancer • Identified 26/623 genes that are mutated at a significantly high frequency – Most frequent: TP53, KRAS, STK11, EGFR – Less frequent: LRP1B, KDR, RB1, LTK, SLC38A3, NRAS • Gen ...
... • Discovery of more than 1,000 somatic mutations after sequencing 623 genes with known or potential relationships to cancer • Identified 26/623 genes that are mutated at a significantly high frequency – Most frequent: TP53, KRAS, STK11, EGFR – Less frequent: LRP1B, KDR, RB1, LTK, SLC38A3, NRAS • Gen ...
UNIVERSITY COLLEGE LONDON CANCER INSTITUTE JOB
... The remit of this post is to undertake computational and statistical analyses on the genomic data (whole genome and targeted sequencing) from sizeable cohorts of subtypes of sarcoma. The results will then be developed using next generation sequencing technologies for diagnostic, predictive and progn ...
... The remit of this post is to undertake computational and statistical analyses on the genomic data (whole genome and targeted sequencing) from sizeable cohorts of subtypes of sarcoma. The results will then be developed using next generation sequencing technologies for diagnostic, predictive and progn ...
Mississippi Cancer Registry - University of Mississippi Medical Center
... – Facilities with <25 cases – Paper abstracts entered into HRN by MCR staff ...
... – Facilities with <25 cases – Paper abstracts entered into HRN by MCR staff ...
SVDetect - Computational Systems Biology of Cancer team at Institut
... Inserm U900, 75248 Paris, France 3 Institut Curie, 26, rue d’Ulm, 75248 Paris, France ...
... Inserm U900, 75248 Paris, France 3 Institut Curie, 26, rue d’Ulm, 75248 Paris, France ...
Big Data–Led Cancer Research, Application, and Insights
... more than 20 tumor types. Analyzing RNA sequencing (RNASeq) and/or whole-genome sequencing (WGS) data from more than 4,000 human tumor samples from TCGA cohorts using PathSeq allowed the identification of resident bacteria, viruses, fungi, bacteriophage, and archaea within each tumor or normal tissue ...
... more than 20 tumor types. Analyzing RNA sequencing (RNASeq) and/or whole-genome sequencing (WGS) data from more than 4,000 human tumor samples from TCGA cohorts using PathSeq allowed the identification of resident bacteria, viruses, fungi, bacteriophage, and archaea within each tumor or normal tissue ...
Cancer Newsletter #1
... sequencing of 100,000 genomes of patients including those with cancer. The main goal of the project is to transform the application of genomics to healthcare in the NHS. The project also aims to increase understanding of tumour variants that predict therapeutic response to targeted cancer drugs and ...
... sequencing of 100,000 genomes of patients including those with cancer. The main goal of the project is to transform the application of genomics to healthcare in the NHS. The project also aims to increase understanding of tumour variants that predict therapeutic response to targeted cancer drugs and ...
Pathogenesis, pathology, clinical features, diagnosis and treatment of
... pyuria, dysuria, burning and frequency are also common at presentation pelvic pain occurs with advanced disease mass may be palpable on bimanual exam urinary cytology is frequently positive for tumor cells Dx is by cystoscopy and transurethral biopsy or resection Bimanual exam under anes ...
... pyuria, dysuria, burning and frequency are also common at presentation pelvic pain occurs with advanced disease mass may be palpable on bimanual exam urinary cytology is frequently positive for tumor cells Dx is by cystoscopy and transurethral biopsy or resection Bimanual exam under anes ...